Unlocking the swirl of genetic information that makes up the double helix of human DNA is only part of the challenge that faces us.
As scientists and citizens, we must address questions and controversies surrounding the use of biotechnology and make choices that will best serve humanity.
The Biotechnology Industry Organization (BIO) is committed to the socially responsible use of biotechnology in health care, food and agriculture, industry and the environment. As biotechnology reaches toward such benefits as treatments for intractable diseases such as cancer, Alzheimer’s and Parkinson’s; abundant, nutritious food; industrial sustainability; and a cleaner world, we encourage public discussion of the ethical, legal and social implications of biotechnology research.
BIO and the biotechnology industry respect the power of the technology we are developing. We believe in the need for regulation, and we insist that this technology — in its myriad of applications — be used to benefit patients and others.
Moreover, BIO supports responsible and ethical testing of new technologies and believes that decisions regarding whether and how to use medical products and technologies always must be made with profound respect for the rights of patients. In our view, appropriate regulation of biotechnology is solidly rooted in values such as autonomy, privacy, beneficence, social justice and intellectual freedom.
BIO’s Statement of Ethical Principles demonstrates a comprehensive vision of how we can ensure that biotechnology is used for human good; we will add to these principles as the technology advances.